ICU MEDICAL INC (ICUI:NASDAQ)
$165.96 -0.66 (-0.3961%)
Analysed ICU MEDICAL INC (ICUI:NASDAQ) News Sources
ICU Medical to Participate in Upcoming Investor Conferences
27-08-2026
yahoo.com
Drug Reconstitution Systems Market Trends, Shares and Growth Opportunities Worldwide 2026-2035 Featuring Profiles of Baxter, ICU Medical, B. Braun, Vetter Pharma, Nipro, SCHOTT-KAISHA
07-09-2026
yahoo.com
ICU Medical CFO Brian Bonnell Sells 9,307 Shares
17-09-2026
fool.com
ICU Medical CFO Sells 6,381 Shares for $1.1 Million
17-09-2026
fool.com
Vascular Access Device Market by Type, Route of Insertion, Application, End User - Global Forecast to 2031
18-09-2026
yahoo.com
ICU Medical (ICUI) Stock May Be 26% Undervalued On Cash Flow
19-09-2026
yahoo.com
2 Volatile Stocks to Target This Week and 1 We Turn Down
28-09-2026
yahoo.com
Is ICU Medical (ICUI) Undervalued After Two FDA Class II Recalls?
07-10-2026
yahoo.com
Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve Cannabis
12-10-2026
yahoo.com
ICU Medical Announces Time of Third Quarter 2026 Earnings Conference Call
22-10-2026
yahoo.com
What is the current price of ICU MEDICAL INC (ICUI:NASDAQ)?
The current price of ICU MEDICAL INC (ICUI:NASDAQ) is $165.96.
ICU MEDICAL INC (ICUI:NASDAQ) absolute price change since previous trading day?
The absolute price change of ICU MEDICAL INC (ICUI:NASDAQ) since the previous trading day is $-0.66.
ICU MEDICAL INC (ICUI:NASDAQ) percentage price change since previous trading day?
The percentage price change of ICU MEDICAL INC (ICUI:NASDAQ) since the previous trading day is -0.3961%.
What is the most recent average sentiment score for ICU MEDICAL INC (ICUI:NASDAQ)?
The most recent average sentiment score for ICU MEDICAL INC (ICUI:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for ICU MEDICAL INC (ICUI:NASDAQ)?
The most recent sentiment for ICU MEDICAL INC (ICUI:NASDAQ) is .
SEC-8K** Filing Available For ICU MEDICAL INC (ICUI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.